##fileformat=VCFv4.2
##fileDate=20260228
##source=HCLS_AI_Factory_Synthetic_Demo_v1.0
##reference=GRCh38/hg38
##INFO=<ID=CSQ,Number=.,Type=String,Description="VEP-style consequence annotation. Format: Consequence|Impact|Gene|GeneID|Transcript|Biotype|Exon|HGVSc|HGVSp|Symbol">
##INFO=<ID=AM,Number=1,Type=Float,Description="AlphaMissense pathogenicity score (0-1). >0.564=likely_pathogenic, 0.34-0.564=ambiguous, <0.34=likely_benign">
##INFO=<ID=CLNSIG,Number=.,Type=String,Description="Clinical significance: Pathogenic, Likely_pathogenic, Uncertain_significance, Likely_benign, Benign">
##FILTER=<ID=PASS,Description="All filters passed">
##FILTER=<ID=LowQual,Description="Quality below threshold">
##FORMAT=<ID=GT,Number=1,Type=String,Description="Genotype">
##FORMAT=<ID=DP,Number=1,Type=Integer,Description="Read depth">
##FORMAT=<ID=GQ,Number=1,Type=Integer,Description="Genotype quality">
##FORMAT=<ID=AD,Number=R,Type=Integer,Description="Allelic depths for the ref and alt alleles">
##contig=<ID=chr1,length=248956422>
##contig=<ID=chr2,length=242193529>
##contig=<ID=chr3,length=198295559>
##contig=<ID=chr4,length=190214555>
##contig=<ID=chr5,length=181538259>
##contig=<ID=chr6,length=170805979>
##contig=<ID=chr7,length=159345973>
##contig=<ID=chr9,length=138394717>
##contig=<ID=chr10,length=133797422>
##contig=<ID=chr11,length=135086622>
##contig=<ID=chr12,length=133275309>
##contig=<ID=chr13,length=114364328>
##contig=<ID=chr14,length=107043718>
##contig=<ID=chr15,length=101991189>
##contig=<ID=chr16,length=90338345>
##contig=<ID=chr17,length=83257441>
##contig=<ID=chr19,length=58617616>
##contig=<ID=chr20,length=64444167>
##contig=<ID=chr22,length=50818468>
##contig=<ID=chrX,length=156040895>
##
## ==========================================================================
## SYNTHETIC DEMO DATA - NOT FOR CLINICAL USE
## ==========================================================================
## This VCF file contains ~90 synthetic variants for demonstration of the
## HCLS AI Factory precision medicine pipeline. All variants are inspired by
## real clinically significant positions but genotype calls, quality scores,
## and some annotation details are fabricated for demo purposes.
##
## DO NOT use this file for any clinical, diagnostic, or treatment decisions.
##
## Coverage: 13 therapeutic areas, 40+ genes from the 201-gene knowledge base
## Variant types: SNPs (~60%), indels (~25%), multi-allelic (~15%)
## Clinical mix: Pathogenic, Likely pathogenic, VUS, Likely benign, Benign
## Impact mix: HIGH (~20%), MODERATE (~50%), LOW (~20%), MODIFIER (~10%)
##
## Created: 2026-02-28
## License: Apache 2.0 (same as parent project)
## ==========================================================================
##
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	SAMPLE
##
## --- NEUROLOGY (14 variants) ---
## VCP gene - Project demo target (Frontotemporal Dementia / IBMPFD)
##
chr9	35065182	rs188935092	G	A	5000	PASS	CSQ=missense_variant|MODERATE|VCP|ENSG00000165280|ENST00000358901|protein_coding|14/17|c.1234G>A|p.Arg412His|VCP;AM=0.87;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:85:99:42,43
chr9	35065301	rs121909334	C	T	4200	PASS	CSQ=missense_variant|HIGH|VCP|ENSG00000165280|ENST00000358901|protein_coding|5/17|c.463C>T|p.Arg155His|VCP;AM=0.93;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:72:99:35,37
chr9	35065478	rs121909335	G	A	3800	PASS	CSQ=missense_variant|HIGH|VCP|ENSG00000165280|ENST00000358901|protein_coding|5/17|c.476G>A|p.Arg159His|VCP;AM=0.91;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:68:98:33,35
chr9	35066910	.	A	G	2500	PASS	CSQ=missense_variant|MODERATE|VCP|ENSG00000165280|ENST00000358901|protein_coding|10/17|c.862A>G|p.Asn288Asp|VCP;AM=0.72;CLNSIG=Uncertain_significance	GT:DP:GQ:AD	0/1:55:95:28,27
chr9	35067200	.	ACTG	A	1800	PASS	CSQ=frameshift_variant|HIGH|VCP|ENSG00000165280|ENST00000358901|protein_coding|12/17|c.1048_1050del|p.Leu350del|VCP;CLNSIG=Likely_pathogenic	GT:DP:GQ:AD	0/1:60:97:32,28
##
## APP gene (Alzheimer disease)
##
chr21	25891796	rs63750847	C	T	6500	PASS	CSQ=missense_variant|HIGH|APP|ENSG00000142192|ENST00000346798|protein_coding|16/18|c.2149G>A|p.Ala717Val|APP;AM=0.96;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:90:99:44,46
chr21	25891798	.	C	T,G	4800	PASS	CSQ=missense_variant|MODERATE|APP|ENSG00000142192|ENST00000346798|protein_coding|16/18|c.2147G>A|p.Val716Met|APP;AM=0.82;CLNSIG=Uncertain_significance	GT:DP:GQ:AD	0/1:78:99:38,25,15
##
## PSEN1 gene (Early-onset Alzheimer)
##
chr14	73170582	rs63751261	G	A	7200	PASS	CSQ=missense_variant|HIGH|PSEN1|ENSG00000080815|ENST00000324501|protein_coding|7/10|c.488G>A|p.Arg163His|PSEN1;AM=0.95;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:95:99:46,49
##
## MAPT gene (Frontotemporal Dementia / Progressive Supranuclear Palsy)
##
chr17	46010397	rs63751273	C	T	3900	PASS	CSQ=missense_variant|MODERATE|MAPT|ENSG00000186868|ENST00000262410|protein_coding|9/13|c.1007C>T|p.Pro301Leu|MAPT;AM=0.88;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:62:98:30,32
##
## HTT gene (Huntington disease - trinucleotide repeat expansion)
##
chr4	3074681	rs1554251837	C	CCAGCAGCAGCAGCAGCAG	2200	PASS	CSQ=inframe_insertion|HIGH|HTT|ENSG00000197386|ENST00000355072|protein_coding|1/67|c.52_69dup|p.Gln18_Gln23dup|HTT;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:48:90:26,22
##
## TARDBP gene (ALS / Frontotemporal Dementia)
##
chr1	11082535	rs80356726	G	A	3100	PASS	CSQ=missense_variant|MODERATE|TARDBP|ENSG00000120948|ENST00000240185|protein_coding|6/6|c.1009A>G|p.Met337Val|TARDBP;AM=0.79;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:58:97:29,29
chr1	11082590	.	GA	G	2800	PASS	CSQ=frameshift_variant|HIGH|TARDBP|ENSG00000120948|ENST00000240185|protein_coding|6/6|c.1050del|p.Gly351fs|TARDBP;CLNSIG=Uncertain_significance	GT:DP:GQ:AD	0/1:52:94:27,25
chr1	11082640	.	G	A	350	LowQual	CSQ=synonymous_variant|LOW|TARDBP|ENSG00000120948|ENST00000240185|protein_coding|6/6|c.1062G>A|p.Leu354%3D|TARDBP;CLNSIG=Benign	GT:DP:GQ:AD	0/1:30:70:16,14
chr1	11082700	.	C	T	180	LowQual	CSQ=3_prime_UTR_variant|MODIFIER|TARDBP|ENSG00000120948|ENST00000240185|protein_coding|-/6|c.*45C>T||TARDBP;CLNSIG=Benign	GT:DP:GQ:AD	0/1:25:55:14,11
##
## --- ONCOLOGY (15 variants) ---
## BRCA1 gene (Hereditary breast/ovarian cancer)
##
chr17	43093449	rs80357906	G	A	8500	PASS	CSQ=stop_gained|HIGH|BRCA1|ENSG00000012048|ENST00000357654|protein_coding|11/23|c.5266G>T|p.Glu1756Ter|BRCA1;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:110:99:55,55
chr17	43094464	rs80357713	TGAG	T	7800	PASS	CSQ=frameshift_variant|HIGH|BRCA1|ENSG00000012048|ENST00000357654|protein_coding|11/23|c.4327_4329del|p.Glu1443del|BRCA1;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:102:99:50,52
chr17	43091983	.	C	T,A	5200	PASS	CSQ=missense_variant|MODERATE|BRCA1|ENSG00000012048|ENST00000357654|protein_coding|15/23|c.4837C>T|p.Pro1613Ser|BRCA1;AM=0.65;CLNSIG=Uncertain_significance	GT:DP:GQ:AD	0/1:88:99:44,28,16
##
## BRCA2 gene (Hereditary breast/ovarian cancer)
##
chr13	32340300	rs80359550	A	AT	6200	PASS	CSQ=frameshift_variant|HIGH|BRCA2|ENSG00000139618|ENST00000380152|protein_coding|11/27|c.5946del|p.Ser1982fs|BRCA2;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:80:99:39,41
chr13	32355250	rs28897743	G	C	4500	PASS	CSQ=missense_variant|MODERATE|BRCA2|ENSG00000139618|ENST00000380152|protein_coding|18/27|c.8167G>C|p.Asp2723His|BRCA2;AM=0.58;CLNSIG=Likely_pathogenic	GT:DP:GQ:AD	0/1:70:99:34,36
##
## TP53 gene (Li-Fraumeni syndrome / pan-cancer)
##
chr17	7674220	rs28934578	G	A	9200	PASS	CSQ=missense_variant|HIGH|TP53|ENSG00000141510|ENST00000269305|protein_coding|7/11|c.742C>T|p.Arg248Trp|TP53;AM=0.97;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:120:99:58,62
chr17	7674945	.	C	T	4100	PASS	CSQ=missense_variant|MODERATE|TP53|ENSG00000141510|ENST00000269305|protein_coding|5/11|c.524G>A|p.Arg175His|TP53;AM=0.94;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:65:99:31,34
##
## EGFR gene (Non-small cell lung cancer)
##
chr7	55191822	rs121434568	T	G	5800	PASS	CSQ=missense_variant|MODERATE|EGFR|ENSG00000146648|ENST00000275493|protein_coding|21/28|c.2573T>G|p.Leu858Arg|EGFR;AM=0.76;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:75:99:36,39
chr7	55174014	rs121913421	GGAATTAAGAGAAGC	G	5100	PASS	CSQ=inframe_deletion|MODERATE|EGFR|ENSG00000146648|ENST00000275493|protein_coding|19/28|c.2235_2249del|p.Glu746_Ala750del|EGFR;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:82:99:41,41
##
## BRAF gene (Melanoma / Colorectal cancer)
##
chr7	140753336	rs113488022	T	A	7500	PASS	CSQ=missense_variant|HIGH|BRAF|ENSG00000157764|ENST00000288602|protein_coding|15/18|c.1799T>A|p.Val600Glu|BRAF;AM=0.89;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:98:99:48,50
##
## KRAS gene (Pancreatic / Colorectal cancer)
##
chr12	25245350	rs121913529	C	A,T	8000	PASS	CSQ=missense_variant|MODERATE|KRAS|ENSG00000133703|ENST00000256078|protein_coding|2/6|c.35G>T|p.Gly12Val|KRAS;AM=0.84;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:105:99:50,35,20
##
## PIK3CA gene (Breast cancer / Ovarian cancer)
##
chr3	179234297	rs121913279	A	G	4600	PASS	CSQ=missense_variant|MODERATE|PIK3CA|ENSG00000121879|ENST00000263967|protein_coding|21/21|c.3140A>G|p.His1047Arg|PIK3CA;AM=0.71;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:72:99:35,37
chr3	179218294	rs121913273	G	A	3800	PASS	CSQ=missense_variant|MODERATE|PIK3CA|ENSG00000121879|ENST00000263967|protein_coding|10/21|c.1633G>A|p.Glu545Lys|PIK3CA;AM=0.68;CLNSIG=Pathogenic	GT:DP:GQ:AD	1/1:60:99:0,60
##
## --- METABOLIC (7 variants) ---
## GCK gene (MODY2 diabetes)
##
chr7	44184184	rs1799884	C	T	3200	PASS	CSQ=missense_variant|MODERATE|GCK|ENSG00000106633|ENST00000403799|protein_coding|7/10|c.766C>T|p.Arg256Cys|GCK;AM=0.73;CLNSIG=Likely_pathogenic	GT:DP:GQ:AD	0/1:56:96:28,28
chr7	44185010	.	G	A	2100	PASS	CSQ=synonymous_variant|LOW|GCK|ENSG00000106633|ENST00000403799|protein_coding|8/10|c.891G>A|p.Pro297%3D|GCK;CLNSIG=Likely_benign	GT:DP:GQ:AD	0/1:42:88:22,20
##
## HNF1A gene (MODY3 diabetes)
##
chr12	120978847	rs137853233	G	A	4100	PASS	CSQ=missense_variant|MODERATE|HNF1A|ENSG00000135100|ENST00000257555|protein_coding|4/10|c.608G>A|p.Arg203His|HNF1A;AM=0.81;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:64:99:31,33
##
## PCSK9 gene (Familial hypercholesterolemia)
##
chr1	55043890	rs11591147	G	T	2800	PASS	CSQ=missense_variant|MODERATE|PCSK9|ENSG00000169174|ENST00000302118|protein_coding|1/12|c.137G>T|p.Arg46Leu|PCSK9;AM=0.42;CLNSIG=Likely_benign	GT:DP:GQ:AD	0/1:50:93:25,25
chr1	55044400	.	C	T	1500	PASS	CSQ=intron_variant|MODIFIER|PCSK9|ENSG00000169174|ENST00000302118|protein_coding|-/12|c.250+15C>T||PCSK9;CLNSIG=Benign	GT:DP:GQ:AD	0/1:35:78:19,16
##
## LDLR gene (Familial hypercholesterolemia)
##
chr19	11200089	rs28942078	C	T	5500	PASS	CSQ=missense_variant|HIGH|LDLR|ENSG00000130164|ENST00000558013|protein_coding|9/18|c.1216C>T|p.Arg406Trp|LDLR;AM=0.90;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:76:99:37,39
chr19	11200200	.	CTGA	C	3200	PASS	CSQ=frameshift_variant|HIGH|LDLR|ENSG00000130164|ENST00000558013|protein_coding|10/18|c.1332_1334del|p.Asp444del|LDLR;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:54:95:28,26
##
## --- RARE DISEASE (8 variants) ---
## CFTR gene (Cystic Fibrosis)
##
chr7	117559590	rs75961395	ATCT	A	6800	PASS	CSQ=inframe_deletion|HIGH|CFTR|ENSG00000001626|ENST00000003084|protein_coding|11/27|c.1521_1523del|p.Phe508del|CFTR;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:88:99:43,45
chr7	117587738	rs78655421	G	A	3600	PASS	CSQ=missense_variant|MODERATE|CFTR|ENSG00000001626|ENST00000003084|protein_coding|14a/27|c.1652G>A|p.Gly551Asp|CFTR;AM=0.85;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:58:97:29,29
chr7	117587800	.	G	A,C	2400	PASS	CSQ=missense_variant|MODERATE|CFTR|ENSG00000001626|ENST00000003084|protein_coding|14a/27|c.1714G>A|p.Asp572Asn|CFTR;AM=0.55;CLNSIG=Uncertain_significance	GT:DP:GQ:AD	0/1:45:90:22,15,8
##
## SMN1 gene (Spinal Muscular Atrophy)
##
chr5	70925030	rs1554286002	C	T	4400	PASS	CSQ=stop_gained|HIGH|SMN1|ENSG00000172062|ENST00000380707|protein_coding|3/8|c.272C>T|p.Gln91Ter|SMN1;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:68:99:33,35
chr5	70925100	.	GCTA	G	3100	PASS	CSQ=frameshift_variant|HIGH|SMN1|ENSG00000172062|ENST00000380707|protein_coding|4/8|c.399_401del|p.Leu134del|SMN1;CLNSIG=Likely_pathogenic	GT:DP:GQ:AD	0/1:52:94:27,25
##
## DMD gene (Duchenne muscular dystrophy)
##
chrX	31496383	rs128627262	G	A	3500	PASS	CSQ=stop_gained|HIGH|DMD|ENSG00000198947|ENST00000357033|protein_coding|44/79|c.6292G>T|p.Glu2098Ter|DMD;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:57:96:28,29
chrX	31497000	.	C	T	800	PASS	CSQ=missense_variant|MODERATE|DMD|ENSG00000198947|ENST00000357033|protein_coding|44/79|c.6340C>T|p.Arg2114Cys|DMD;AM=0.61;CLNSIG=Uncertain_significance	GT:DP:GQ:AD	0/1:38:82:20,18
##
## FMR1 gene (Fragile X syndrome)
##
chrX	147912050	rs1555050497	C	CCGGCGGCGGCGGCGG	1200	PASS	CSQ=inframe_insertion|HIGH|FMR1|ENSG00000102081|ENST00000370475|protein_coding|1/17|c.99_113dup|p.Arg33_Arg37dup|FMR1;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:40:85:22,18
##
## --- HEMATOLOGY (6 variants) ---
## HBB gene (Sickle cell disease / Beta-thalassemia)
##
chr11	5227002	rs334	T	A	9500	PASS	CSQ=missense_variant|HIGH|HBB|ENSG00000244734|ENST00000335295|protein_coding|1/3|c.20A>T|p.Glu7Val|HBB;AM=0.92;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:125:99:61,64
chr11	5226968	rs33930165	C	T	3500	PASS	CSQ=stop_gained|HIGH|HBB|ENSG00000244734|ENST00000335295|protein_coding|1/3|c.52C>T|p.Gln18Ter|HBB;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:57:96:28,29
##
## JAK2 gene (Myeloproliferative neoplasms)
##
chr9	5073770	rs77375493	G	T	7000	PASS	CSQ=missense_variant|MODERATE|JAK2|ENSG00000096968|ENST00000381652|protein_coding|14/25|c.1849G>T|p.Val617Phe|JAK2;AM=0.83;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:92:99:45,47
chr9	5073800	.	G	A	500	PASS	CSQ=synonymous_variant|LOW|JAK2|ENSG00000096968|ENST00000381652|protein_coding|14/25|c.1860G>A|p.Ala620%3D|JAK2;CLNSIG=Benign	GT:DP:GQ:AD	0/1:32:75:17,15
##
## CALR gene (Myeloproliferative neoplasms)
##
chr19	13049523	rs1238643904	CTTGTC	C	4800	PASS	CSQ=frameshift_variant|HIGH|CALR|ENSG00000179218|ENST00000316448|protein_coding|9/9|c.1099_1103del|p.Leu367fs|CALR;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:74:99:36,38
chr19	13049600	.	G	T,C	2200	PASS	CSQ=missense_variant|MODERATE|CALR|ENSG00000179218|ENST00000316448|protein_coding|9/9|c.1175G>T|p.Cys392Phe|CALR;AM=0.48;CLNSIG=Uncertain_significance	GT:DP:GQ:AD	0/1:44:89:22,14,8
##
## --- CARDIOVASCULAR (7 variants) ---
## MYBPC3 gene (Hypertrophic cardiomyopathy)
##
chr11	47352957	rs397515963	C	T	5600	PASS	CSQ=missense_variant|MODERATE|MYBPC3|ENSG00000134571|ENST00000545968|protein_coding|18/35|c.1504C>T|p.Arg502Trp|MYBPC3;AM=0.86;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:78:99:38,40
chr11	47353100	.	GACT	G	4200	PASS	CSQ=frameshift_variant|HIGH|MYBPC3|ENSG00000134571|ENST00000545968|protein_coding|19/35|c.1618_1620del|p.Lys540del|MYBPC3;CLNSIG=Likely_pathogenic	GT:DP:GQ:AD	0/1:66:98:33,33
##
## SCN5A gene (Brugada syndrome / Long QT)
##
chr3	38589557	rs137854608	G	A	4900	PASS	CSQ=missense_variant|MODERATE|SCN5A|ENSG00000183873|ENST00000413689|protein_coding|28/28|c.5350G>A|p.Glu1784Lys|SCN5A;AM=0.88;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:74:99:36,38
chr3	38589600	.	C	G	1900	PASS	CSQ=missense_variant|MODERATE|SCN5A|ENSG00000183873|ENST00000413689|protein_coding|28/28|c.5393C>G|p.Ser1798Cys|SCN5A;AM=0.52;CLNSIG=Uncertain_significance	GT:DP:GQ:AD	0/1:42:87:22,20
##
## KCNQ1 gene (Long QT syndrome)
##
chr11	2549082	rs120074175	C	T	5100	PASS	CSQ=missense_variant|MODERATE|KCNQ1|ENSG00000053918|ENST00000155840|protein_coding|6/16|c.797C>T|p.Ala266Val|KCNQ1;AM=0.80;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:76:99:37,39
chr11	2549100	.	C	T	420	PASS	CSQ=synonymous_variant|LOW|KCNQ1|ENSG00000053918|ENST00000155840|protein_coding|6/16|c.810C>T|p.Ile270%3D|KCNQ1;CLNSIG=Likely_benign	GT:DP:GQ:AD	0/1:33:74:18,15
chr11	2549200	.	A	G	250	LowQual	CSQ=intron_variant|MODIFIER|KCNQ1|ENSG00000053918|ENST00000155840|protein_coding|-/16|c.815+25A>G||KCNQ1;CLNSIG=Benign	GT:DP:GQ:AD	0/1:28:62:16,12
##
## --- PHARMACOGENOMICS (7 variants) ---
## CYP2D6 gene (Drug metabolism - codeine, tamoxifen, etc.)
##
chr22	42127941	rs3892097	G	A	3800	PASS	CSQ=splice_acceptor_variant|HIGH|CYP2D6|ENSG00000100197|ENST00000360610|protein_coding|3/9|c.506-1G>A||CYP2D6;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:60:97:30,30
chr22	42128174	rs16947	G	A	2500	PASS	CSQ=missense_variant|MODERATE|CYP2D6|ENSG00000100197|ENST00000360610|protein_coding|6/9|c.886T>C|p.Arg296Cys|CYP2D6;AM=0.38;CLNSIG=Likely_benign	GT:DP:GQ:AD	1/1:46:92:0,46
##
## CYP2C19 gene (Drug metabolism - clopidogrel, PPIs)
##
chr10	94781859	rs4244285	G	A	3200	PASS	CSQ=splice_donor_variant|HIGH|CYP2C19|ENSG00000165841|ENST00000371321|protein_coding|5/9|c.681+1G>A||CYP2C19;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:54:95:27,27
chr10	94781900	.	C	T	1800	PASS	CSQ=missense_variant|MODERATE|CYP2C19|ENSG00000165841|ENST00000371321|protein_coding|5/9|c.670C>T|p.Pro224Ser|CYP2C19;AM=0.45;CLNSIG=Uncertain_significance	GT:DP:GQ:AD	0/1:40:85:21,19
##
## DPYD gene (Dihydropyrimidine dehydrogenase deficiency - 5-FU toxicity)
##
chr1	97515839	rs3918290	G	A	6000	PASS	CSQ=splice_donor_variant|HIGH|DPYD|ENSG00000188641|ENST00000370192|protein_coding|14/23|c.1905+1G>A||DPYD;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:82:99:40,42
chr1	97547947	rs67376798	T	A	3500	PASS	CSQ=missense_variant|MODERATE|DPYD|ENSG00000188641|ENST00000370192|protein_coding|13/23|c.1679T>A|p.Ile560Asn|DPYD;AM=0.74;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:56:96:28,28
chr1	97548000	.	G	A	600	PASS	CSQ=synonymous_variant|LOW|DPYD|ENSG00000188641|ENST00000370192|protein_coding|13/23|c.1692G>A|p.Ala564%3D|DPYD;CLNSIG=Benign	GT:DP:GQ:AD	0/1:34:76:18,16
##
## --- IMMUNOLOGY (6 variants) ---
## HLA-B gene (Drug hypersensitivity - abacavir, carbamazepine)
##
chr6	31356172	rs1071654	A	G	4200	PASS	CSQ=missense_variant|MODERATE|HLA-B|ENSG00000234745|ENST00000412585|protein_coding|3/8|c.346A>G|p.Ile116Val|HLA-B;AM=0.55;CLNSIG=Likely_pathogenic	GT:DP:GQ:AD	0/1:66:98:33,33
chr6	31356200	.	C	G,T	2800	PASS	CSQ=missense_variant|MODERATE|HLA-B|ENSG00000234745|ENST00000412585|protein_coding|3/8|c.374C>G|p.Ala125Gly|HLA-B;AM=0.41;CLNSIG=Uncertain_significance	GT:DP:GQ:AD	0/1:48:90:24,16,8
##
## CTLA4 gene (Autoimmune lymphoproliferative syndrome)
##
chr2	203867991	rs231775	A	G	2600	PASS	CSQ=missense_variant|MODERATE|CTLA4|ENSG00000163599|ENST00000302823|protein_coding|1/4|c.49A>G|p.Thr17Ala|CTLA4;AM=0.35;CLNSIG=Likely_benign	GT:DP:GQ:AD	1/1:48:93:0,48
chr2	203868050	.	A	G	400	PASS	CSQ=synonymous_variant|LOW|CTLA4|ENSG00000163599|ENST00000302823|protein_coding|1/4|c.60A>G|p.Leu20%3D|CTLA4;CLNSIG=Benign	GT:DP:GQ:AD	0/1:30:72:16,14
##
## IL6 gene (Systemic inflammation / cytokine storm)
##
chr7	22725889	rs1800795	G	C	2200	PASS	CSQ=5_prime_UTR_variant|MODIFIER|IL6|ENSG00000136244|ENST00000258743|protein_coding|-/5|c.-174G>C||IL6;CLNSIG=Likely_benign	GT:DP:GQ:AD	0/1:44:88:22,22
chr7	22725950	.	A	C	300	LowQual	CSQ=intron_variant|MODIFIER|IL6|ENSG00000136244|ENST00000258743|protein_coding|-/5|c.87+30A>C||IL6;CLNSIG=Benign	GT:DP:GQ:AD	0/1:26:60:15,11
##
## --- RESPIRATORY (4 variants) ---
## SERPINA1 gene (Alpha-1 antitrypsin deficiency)
##
chr14	94378610	rs28929474	C	T	5400	PASS	CSQ=missense_variant|MODERATE|SERPINA1|ENSG00000197249|ENST00000355814|protein_coding|5/5|c.1096G>A|p.Glu366Lys|SERPINA1;AM=0.82;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:76:99:37,39
chr14	94378700	.	G	A	1200	PASS	CSQ=missense_variant|MODERATE|SERPINA1|ENSG00000197249|ENST00000355814|protein_coding|5/5|c.1186G>A|p.Gly396Ser|SERPINA1;AM=0.45;CLNSIG=Uncertain_significance	GT:DP:GQ:AD	0/1:38:83:20,18
##
## DNAI1 gene (Primary ciliary dyskinesia)
##
chr9	34460552	rs76715226	G	A	3000	PASS	CSQ=missense_variant|MODERATE|DNAI1|ENSG00000122735|ENST00000242317|protein_coding|13/20|c.1301G>A|p.Arg434Gln|DNAI1;AM=0.67;CLNSIG=Likely_pathogenic	GT:DP:GQ:AD	0/1:52:94:26,26
chr9	34460600	.	CTAG	C	2200	PASS	CSQ=frameshift_variant|HIGH|DNAI1|ENSG00000122735|ENST00000242317|protein_coding|14/20|c.1385_1387del|p.Ile462del|DNAI1;CLNSIG=Likely_pathogenic	GT:DP:GQ:AD	0/1:44:89:23,21
##
## --- OPHTHALMOLOGY (4 variants) ---
## RHO gene (Retinitis pigmentosa)
##
chr3	129528548	rs29001653	C	T	4800	PASS	CSQ=missense_variant|MODERATE|RHO|ENSG00000163914|ENST00000296271|protein_coding|2/5|c.403C>T|p.Pro347Leu|RHO;AM=0.90;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:74:99:36,38
chr3	129528600	.	G	A	1600	PASS	CSQ=missense_variant|LOW|RHO|ENSG00000163914|ENST00000296271|protein_coding|2/5|c.455G>A|p.Arg152Gln|RHO;AM=0.33;CLNSIG=Likely_benign	GT:DP:GQ:AD	0/1:38:82:20,18
##
## RPE65 gene (Leber congenital amaurosis - Luxturna gene therapy target)
##
chr1	68416115	rs62636275	C	T	5200	PASS	CSQ=missense_variant|MODERATE|RPE65|ENSG00000116745|ENST00000262340|protein_coding|7/14|c.646C>T|p.Arg216Cys|RPE65;AM=0.86;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:78:99:38,40
chr1	68416200	.	G	A,T	2000	PASS	CSQ=missense_variant|MODERATE|RPE65|ENSG00000116745|ENST00000262340|protein_coding|7/14|c.731G>A|p.Arg244His|RPE65;AM=0.60;CLNSIG=Uncertain_significance	GT:DP:GQ:AD	0/1:42:87:21,13,8
##
## --- GI / HEPATOLOGY (5 variants) ---
## APC gene (Familial adenomatous polyposis / Colorectal cancer)
##
chr5	112839514	rs121913332	C	T	7200	PASS	CSQ=stop_gained|HIGH|APC|ENSG00000134982|ENST00000257430|protein_coding|16/16|c.3927C>T|p.Arg1309Ter|APC;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:94:99:46,48
chr5	112839600	.	GCTA	G	4500	PASS	CSQ=frameshift_variant|HIGH|APC|ENSG00000134982|ENST00000257430|protein_coding|16/16|c.4012_4014del|p.Ile1338del|APC;CLNSIG=Likely_pathogenic	GT:DP:GQ:AD	0/1:70:99:34,36
##
## MLH1 gene (Lynch syndrome / Hereditary nonpolyposis colorectal cancer)
##
chr3	37034946	rs63750217	G	A	5800	PASS	CSQ=missense_variant|MODERATE|MLH1|ENSG00000076242|ENST00000231790|protein_coding|12/19|c.1151T>A|p.Val384Asp|MLH1;AM=0.78;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:80:99:39,41
chr3	37035000	.	C	T	2200	PASS	CSQ=missense_variant|MODERATE|MLH1|ENSG00000076242|ENST00000231790|protein_coding|12/19|c.1205C>T|p.Thr402Met|MLH1;AM=0.48;CLNSIG=Uncertain_significance	GT:DP:GQ:AD	0/1:44:89:23,21
chr3	37035100	.	G	C	350	LowQual	CSQ=synonymous_variant|LOW|MLH1|ENSG00000076242|ENST00000231790|protein_coding|12/19|c.1218G>C|p.Glu406%3D|MLH1;CLNSIG=Benign	GT:DP:GQ:AD	0/1:29:68:16,13
##
## --- INFECTIOUS DISEASE (4 variants) ---
## CCR5 gene (HIV-1 resistance / co-receptor)
##
chr3	46373453	rs333	TACATCAATTATTATACATCGTC	T	4000	PASS	CSQ=frameshift_variant|HIGH|CCR5|ENSG00000160791|ENST00000292303|protein_coding|3/4|c.554_575del|p.Ser185fs|CCR5;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:62:98:31,31
##
## IFITM3 gene (Influenza susceptibility)
##
chr11	319687	rs12252	T	C	2800	PASS	CSQ=missense_variant|MODERATE|IFITM3|ENSG00000142089|ENST00000399808|protein_coding|1/2|c.34T>C|p.Leu12Pro|IFITM3;AM=0.44;CLNSIG=Likely_benign	GT:DP:GQ:AD	1/1:50:94:0,50
##
## TLR7 gene (COVID-19 severity)
##
chrX	12888082	rs201024042	C	T	3400	PASS	CSQ=missense_variant|MODERATE|TLR7|ENSG00000196664|ENST00000354958|protein_coding|3/3|c.2129C>T|p.Pro710Leu|TLR7;AM=0.71;CLNSIG=Likely_pathogenic	GT:DP:GQ:AD	0/1:56:96:28,28
chrX	12888150	.	G	A	700	PASS	CSQ=synonymous_variant|LOW|TLR7|ENSG00000196664|ENST00000354958|protein_coding|3/3|c.2181G>A|p.Ala727%3D|TLR7;CLNSIG=Benign	GT:DP:GQ:AD	0/1:35:78:19,16
##
## --- DERMATOLOGY (5 variants) ---
## FLG gene (Atopic dermatitis / Ichthyosis vulgaris)
##
chr1	152285861	rs61816761	G	A	5500	PASS	CSQ=stop_gained|HIGH|FLG|ENSG00000143631|ENST00000368799|protein_coding|3/3|c.2282_2285del|p.Ser761Ter|FLG;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:76:99:37,39
chr1	152286000	.	CT	C	3200	PASS	CSQ=frameshift_variant|HIGH|FLG|ENSG00000143631|ENST00000368799|protein_coding|3/3|c.3321del|p.Ser1107fs|FLG;CLNSIG=Pathogenic	GT:DP:GQ:AD	0/1:54:95:28,26
chr1	152286200	.	G	A	800	PASS	CSQ=missense_variant|LOW|FLG|ENSG00000143631|ENST00000368799|protein_coding|3/3|c.3500G>A|p.Ser1167Asn|FLG;AM=0.22;CLNSIG=Likely_benign	GT:DP:GQ:AD	0/1:36:80:19,17
##
## MC1R gene (Melanoma risk / Red hair phenotype)
##
chr16	89919709	rs1805007	C	T	2600	PASS	CSQ=missense_variant|MODERATE|MC1R|ENSG00000258839|ENST00000555147|protein_coding|1/1|c.478C>T|p.Arg160Trp|MC1R;AM=0.53;CLNSIG=Likely_pathogenic	GT:DP:GQ:AD	0/1:48:91:24,24
chr16	89919736	rs1805008	C	T	2200	PASS	CSQ=missense_variant|MODERATE|MC1R|ENSG00000258839|ENST00000555147|protein_coding|1/1|c.451C>T|p.Arg151Cys|MC1R;AM=0.47;CLNSIG=Likely_pathogenic	GT:DP:GQ:AD	1/1:44:88:0,44
